TP53 and neoplasm: Specifically, molecular analysis of the patient’s jejunal tumor sample revealed a high PD-L1 expression level (90%), the presence of a METex14 mutation (VAF 49.9%), and a TP53 mutation (VAF 33.7%), as determined by NGS.